Wikipedia -WSS

Wikipedia

author：entertainment 2025-08-19 18:07:05 - browse：8611

Several amyloid plaques forming between neurons in a brain — Amyloid plaques forming between neurons. Adobe

The Food and Drug Administration on Thursday granted full approval to the first therapy for Alzheimer’s disease clearly shown to slow the cognitive decline associated with the disease — a milestone in treatment, even if the benefits are modest.

The drug, called Leqembi, was developed by Eisai, the Japanese pharmaceutical company, and sold in partnership with Biogen. It previously secured conditional approval in January. The FDA’s decision will broaden patient access to the drug under the Medicare program and is likely to boost sales, even as Leqembi’s benefits and safety risks continue to be a source of debate.

Leqembi’s full, or traditional, approval was supported by results of a large clinical trial in which the drug slowed the rate of cognitive and functional decline by 27% compared to a placebo. Leqembi also beat placebo on a series of secondary measures of Alzheimer’s, and it had a dramatic effect on clearing toxic brain plaques called beta-amyloid, which play a role in the progression of the disease.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Addressing health care workers' trauma can help fight burnout

entertainment

Wikipedia

WSS

Making the case for fair compensation in clinical trials

FDA poised to publish guidelines for clinical trial diversity

Female surgeons have lower rates of long

UnitedHealth argues against case alleging wrongful AI care denials

ASCO eve: Let’s set the table for this year's meeting

ASCO eve: Let’s set the table for this year's meeting

knowledge

Wikipedia

entertainment

Wildfire smoke exposes gaps in outdoor worker protections

Listen: A conversation with researcher Kevin Esvelt on biosecurity

At least 13 dead in Texas as scorching temps continue

European regulators recommend Amylyx's ALS drug be rejected

Sports medicine is finally prioritizing gender equality

Study finds gene variants tied to breast cancer risk in Black women

Cancer drug shortages should be causing more outrage

Cancer cells are shown to suck energy source from immune cells

BioMarin wins approval for gene therapy to treat hemophilia A

Researchers CRISPR chickens in bid to protect them from bird flu

focus

European regulators consider appeal over Amylyx ALS drug

Eyeing GLP

ASCO eve: Let’s set the table for this year's meeting

Questions and answers about ramping up H5N1 bird flu vaccine

H5N1 virus can be tracked in retail milk, scientists say

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

entertainment

Wikipedia

hotspot

hotspot